Literature DB >> 1466596

Comparison of two approaches to measuring change in health status in rheumatoid arthritis: the Health Assessment Questionnaire (HAQ) and modified HAQ.

S Ziebland1, R Fitzpatrick, C Jenkinson, A Mowat, A Mowat.   

Abstract

As an alternative to the calculation of change scores for health status questionnaires used in clinical trials or longitudinal studies, transitional questions have been developed for patients to assess changes directly themselves. Here the original Health Assessment Questionnaire (HAQ) is compared with a modified version of the HAQ (MHAQ) which contains transition questions used at follow up. These, together with a set of standard rheumatological tests, were all completed by 100 patients with rheumatoid arthritis on two occasions, three months apart. Change scores were calculated for the HAQ and for the clinical measures and compared with the MHAQ. The results were strikingly in favour of encouraging patients to assess their own degree of change through the use of transition questions in the MHAQ.

Entities:  

Mesh:

Year:  1992        PMID: 1466596      PMCID: PMC1012455          DOI: 10.1136/ard.51.11.1202

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  Predictors of disability in a longitudinal sample of patients with rheumatoid arthritis.

Authors:  J P Leigh; J F Fries
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

2.  A comparison of measures of health status in rheumatoid arthritis.

Authors:  R Fitzpatrick; S Newman; R Lamb; M Shipley
Journal:  Br J Rheumatol       Date:  1989-06

3.  Multidimensional assessment of functional limitations in patients with arthritis.

Authors:  A A Guccione; A M Jette
Journal:  Arthritis Care Res       Date:  1990-03

4.  Determinants of disability in rheumatoid arthritis.

Authors:  A C McFarlane; P M Brooks
Journal:  Br J Rheumatol       Date:  1988-02

5.  Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis.

Authors:  J R Kirwan; J S Reeback
Journal:  Br J Rheumatol       Date:  1986-05

6.  Assessment of disability caused by rheumatic diseases in general practice.

Authors:  F M Sullivan; R C Eagers; K Lynch; J H Barber
Journal:  Ann Rheum Dis       Date:  1987-08       Impact factor: 19.103

7.  Outcome assessment in clinical trials. Evidence for the sensitivity of a health status measure.

Authors:  R F Meenan; J J Anderson; L E Kazis; M J Egger; M Altz-Smith; C O Samuelson; R F Willkens; M A Solsky; S P Hayes; K L Blocka
Journal:  Arthritis Rheum       Date:  1984-12

8.  Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.

Authors:  G Borg; E Allander; B Lund; E Berg; U Brodin; H Pettersson; L Trang
Journal:  J Rheumatol       Date:  1988-12       Impact factor: 4.666

9.  Clinical and health status measures over time: prognosis and outcome assessment in rheumatoid arthritis.

Authors:  F Wolfe; D J Hawley; M A Cathey
Journal:  J Rheumatol       Date:  1991-09       Impact factor: 4.666

10.  The assessment of disease activity in rheumatoid arthritis using a multivariate analysis.

Authors:  R K Mallya; B E Mace
Journal:  Rheumatol Rehabil       Date:  1981-02-01
View more
  27 in total

1.  Health Assessment Questionnaire modifications: is standardisation needed?

Authors:  M M Zandbelt; P M Welsing; A M van Gestel; P L van Riel
Journal:  Ann Rheum Dis       Date:  2001-09       Impact factor: 19.103

2.  Best practice in symptom assessment: a review.

Authors:  E McColl
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

3.  Gender-associated comorbidities in rheumatoid arthritis and their impact on outcome: data from GENIRA.

Authors:  E Aurrecoechea; J Llorca Díaz; M L Diez Lizuain; G McGwin; J Calvo-Alen
Journal:  Rheumatol Int       Date:  2016-12-16       Impact factor: 2.631

4.  Ceiling effects of the Health Assessment Questionnaire and its modified version in some ambulatory rheumatoid arthritis patients.

Authors:  G Stucki; S Stucki; P Brühlmann; B A Michel
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

5.  Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting.

Authors:  R Harper; J E Brazier; J C Waterhouse; S J Walters; N M Jones; P Howard
Journal:  Thorax       Date:  1997-10       Impact factor: 9.139

6.  Targeting motivation and self-regulation to increase physical activity among patients with rheumatoid arthritis: a randomised controlled trial.

Authors:  Keegan Knittle; Veronique De Gucht; Emalie Hurkmans; Andre Peeters; Karel Ronday; Stan Maes; Thea Vliet Vlieland
Journal:  Clin Rheumatol       Date:  2013-11-09       Impact factor: 2.980

7.  The short form 36 health status questionnaire: clues from the Oxford region's normative data about its usefulness in measuring health gain in population surveys.

Authors:  S Ziebland
Journal:  J Epidemiol Community Health       Date:  1995-02       Impact factor: 3.710

8.  Meaning behind measurement: self-comparisons affect responses to health-related quality of life questionnaires.

Authors:  Clare Robertson; Anne L Langston; Sally Stapley; Elaine McColl; Marion K Campbell; William D Fraser; Graeme Maclennan; Peter L Selby; Stuart H Ralston; Peter M Fayers
Journal:  Qual Life Res       Date:  2009-01-14       Impact factor: 4.147

9.  Remission in psoriatic arthritis: is it possible and how can it be predicted?

Authors:  Tajvur P Saber; C T Ng; Guillaume Renard; Bernadette M Lynch; Eliza Pontifex; Ceara A E Walsh; Alexia Grier; Marian Molloy; Barry Bresnihan; Oliver Fitzgerald; Ursula Fearon; Douglas J Veale
Journal:  Arthritis Res Ther       Date:  2010-05-18       Impact factor: 5.156

10.  Comparison of the sensitivity to change of long and short form pain measures.

Authors:  C Jenkinson; D Carroll; M Egerton; T Frankland; H McQuay; C Nagle
Journal:  Qual Life Res       Date:  1995-08       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.